The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer-Reference-Cited by-同舟云学术

The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer

Published:2015-11-17 Issue: Volume:6 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Rezvani Katayoun,Rouce Rayne H.

Funder

Lymphoma Research Foundation

Lymphoma SPORE

University of Texas MD Anderson Cancer Center

Sister Institution Network Fund

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference116 articles.

1. Inhibition of clonogenic growth of fresh leukemia cells by unstimulated and IL-2 stimulated NK cells of normal donors;Lotzova;Leuk Res,1987

2. Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells;Lowdell;Br J Haematol,2002

3. Opportunities and limitations of NK cells as adoptive therapy for malignant disease;Davies;Cytotherapy,2014

4. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes;Lanier;J Immunol,1986

5. Natural killer cells in the treatment of high-risk acute leukaemia;Locatelli;Semin Immunol,2014

Cited by 210 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-expression of IL-21-Enhanced NKG2D CAR-NK cell therapy for lung cancer;BMC Cancer;2024-01-23

2. MRI radiomics to monitor therapeutic outcome of sorafenib plus IHA transcatheter NK cell combination therapy in hepatocellular carcinoma;Journal of Translational Medicine;2024-01-19

3. Mini review: Advances and challenges in CAR-T cell therapy: from early chimeric antigen receptors to future frontiers in oncology;Frontiers in Hematology;2023-11-28

4. Charting a killer course to the solid tumor: strategies to recruit and activate NK cells in the tumor microenvironment;Frontiers in Immunology;2023-11-08

5. Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment;Frontiers in Oncology;2023-11-03